Literature DB >> 24659874

Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Francesco Vasuri1, Deborah Malvi1, Elisa Gruppioni1, Walter F Grigioni1, Antonia D'Errico-Grigioni1.   

Abstract

Although the morphological features of hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) have been well established in the last decades, the differential diagnosis still represents a challenge for the pathologist, especially early recurrent hepatitis C vs mild acute cellular rejection. The present review focuses on the role of the pathologist and the pathology laboratory in the management of recipients with recurrent hepatitis C, the usefulness of early and late post-OLT liver biopsies, and the potential role of ancillary techniques (immunohistochemistry and reverse transcription-polymerase chain reaction, RT-PCR). The English literature on the topic is reviewed, focusing on the histopathology, the immunohistochemistry and the use of RT-PCR on HCV-positive post-OLT biopsies. The different histopathological illustrations of early and chronic recurrent hepatitis C are presented, with special focus on the main differential diagnoses and those features with prognostic relevance (cholestasis above all). The usefulness of ancillary techniques are discussed, especially HCV RNA quantitation by RT-PCR. Finally, the usefulness of long-term protocol biopsies is addressed: their usefulness for the study of allograft disease progression is clear, but their meaning in the long term is still debated. The significance of plasma cell infiltrate in HCV-positive allografts, the prognostic weight of graft steatosis, and the impact of donor age in recurrent hepatitis C also represent additional open issues.

Entities:  

Keywords:  Hepatitis C virus; Histopathology; Immunohistochemistry; Orthotopic liver transplantation; Polymerase chain reaction; Recurrent hepatitis C

Mesh:

Year:  2014        PMID: 24659874      PMCID: PMC3961976          DOI: 10.3748/wjg.v20.i11.2810

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  136 in total

Review 1.  Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria.

Authors:  Tarun K Narang; Will Ahrens; Mark W Russo
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

2.  Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.

Authors:  R Sreekumar; A Gonzalez-Koch; Y Maor-Kendler; K Batts; L Moreno-Luna; J Poterucha; L Burgart; R Wiesner; W Kremers; C Rosen; M R Charlton
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

3.  Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.

Authors:  G J McKenna; J F Trotter; E Klintmalm; N Onaca; R Ruiz; L W Jennings; M Neri; J G O'Leary; G L Davis; M F Levy; R M Goldstein; G B Klintmalm
Journal:  Am J Transplant       Date:  2011-10-03       Impact factor: 8.086

4.  The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.

Authors:  R Teixeira; S Pastacaldi; S Davies; A P Dhillon; V C Emery; K Rolles; B Davidson; D Patch; A K Burroughs
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

5.  Nonspecificity of monoclonal antibody Tordji-22 for the detection of hepatitis C virus in liver transplant recipients with cholestatic hepatitis.

Authors:  A L Doughty; D M Painter; G W McCaughan
Journal:  Liver Transpl Surg       Date:  1999-01

6.  Evolution of hepatitis C virus in liver allografts.

Authors:  Anthony J Demetris
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

7.  Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.

Authors:  M I Fiel; D Shukla; N Saraf; R Xu; T D Schiano
Journal:  Transpl Infect Dis       Date:  2007-10-01       Impact factor: 2.228

8.  The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.

Authors:  Hiroyuki Sugo; Glenda A Balderson; Darrell H G Crawford; Jonathan Fawcett; Stephen V Lynch; Russell W Strong; Shunji Futagawa
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

9.  Long-term outcome of hepatitis C infection after liver transplantation.

Authors:  E J Gane; B C Portmann; N V Naoumov; H M Smith; J A Underhill; P T Donaldson; G Maertens; R Williams
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

10.  Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.

Authors:  Hiroshi Sadamori; Takahito Yagi; Hiromi Iwagaki; Hiroaki Matsuda; Susumu Shinoura; Yuzo Umeda; Nobuya Ohara; Hiroyuki Yanai; Tetsuya Ogino; Noriaki Tanaka
Journal:  J Gastroenterol Hepatol       Date:  2009-04       Impact factor: 4.029

View more
  2 in total

Review 1.  De novo autoimmune hepatitis in liver transplant: State-of-the-art review.

Authors:  Ranka Vukotic; Giovanni Vitale; Antonia D'Errico-Grigioni; Luigi Muratori; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 2.  Liver pathology of hepatitis C, beyond grading and staging of the disease.

Authors:  Sadhna Dhingra; Stephen C Ward; Swan N Thung
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.